Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Muscular Atrophy × Olanzapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 2 Nausea 2 Postoperative Nausea and Vomiting 1 Neoplasms 1 Muscular Atrophy 1 Child Nutrition Disorders 1

Interventions

Standard of Care 1 Olanzapine 1 Enteral Nutrition 1 Cyproheptadine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06175273 2025-09-18

POINT

University of Kentucky

Phase 2/3 Completed

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡